{"id": "dsdw8c", "title": "$ESPR - new cholesterol lowering drug", "selftext": "I'm a financial retard but I work in medical so there's that.\n\nESPR (Esperion): They are announcing earnings today, but most importantly they have a drug that looks like it is definitely going to be approved by FDA by Feb 2020. It's a cholesterol-lowering medication with 'no' side effects (unlike statins) and has been recently mentioned by cleaveland clinic -\n\n[https://www.globenewswire.com/news-release/2019/10/25/1935745/0/en/Bempedoic-Acid-Included-in-Top-10-Medical-Innovations-for-2020-List.html](https://www.globenewswire.com/news-release/2019/10/25/1935745/0/en/Bempedoic-Acid-Included-in-Top-10-Medical-Innovations-for-2020-List.html)\n\nThe company and director were part of Pfizer. \n\nThey're also reporting phase 3 results Nov 17; doubt they would have announced this if the results were negative - \n\n[https://finance.yahoo.com/news/esperion-announces-pooled-analyses-phase-123000512.html](https://finance.yahoo.com/news/esperion-announces-pooled-analyses-phase-123000512.html)\n\nMore Study results - \n\n [https://www.acc.org/latest-in-cardiology/articles/2019/05/03/10/20/bempedoic-acid-the-next-ldl-cholesterol-lowering-medication-to-join-the-arsenal](https://www.acc.org/latest-in-cardiology/articles/2019/05/03/10/20/bempedoic-acid-the-next-ldl-cholesterol-lowering-medication-to-join-the-arsenal) \n\nI've loaded up on calls for Nov 15 and also for March 2020 and bought some shares. If it ends up going lower after earnings (they're currently cash negative), I'll load up on some more shares and calls for after Feb 2020. Once the drug hits the market, this is going to shoot up.", "created_utc": 1573032013, "permalink": "/r/wallstreetbets/comments/dsdw8c/espr_new_cholesterol_lowering_drug/", "is_self": true}